Home » Topics » BioWorld Science

BioWorld Science
RSS

PU.1 controls yin and yang of fibrosis

Feb. 6, 2019

Aging causes cancer, cancer causes aging

Feb. 6, 2019

Novel chimeric DNA vaccine shows prophylactic and therapeutic effect against cervical cancer in mice

Feb. 5, 2019

Reduction of BACE1 protein levels by MMP-13 inhibition shows therapeutic potential for AD in mice

Feb. 5, 2019

NIH grant supports Syntrix in development of SX-682 for MDS

Feb. 5, 2019

SBRI funding supports Amprologix's development of epidermicin NI-01

Feb. 5, 2019

FDA accepts IND for Spero's phase III study of SPR-994 for cUTI

Feb. 5, 2019

ICMR and collaborators identify new PTP-1B inhibitors

Feb. 5, 2019

Atatuerk Ueniversitesi describes new compounds for cancer

Feb. 5, 2019

Theralase reports further phase Ib data on TLD-1433 in nonmuscle invasive bladder cancer

Feb. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...